Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Prevalence of Atherosclerosis in diabetic and non-diabetic patients with rheumatoid arthritis.

Pakistan journal of medical sciences

Kisiel B, Kruszewski R, Juszkiewicz A, Kłos K, Tłustochowicz M, Tłustochowicz W.
PMID: 26648990
Pak J Med Sci. 2015 Sep-Oct;31(5):1078-83. doi: 10.12669/pjms.315.7620.

OBJECTIVES: (1) To compare the prevalence of preclinical atherosclerosis in diabetic vs. non-diabetic rheumatoid arthritis (RA) patients; (2) to determine the influence of classical and RA-related factors on atherosclerosis; (3) to assess the usefulness of combined carotid and femoral...

Cite
Kisiel B, Kruszewski R, Juszkiewicz A, et al. Prevalence of Atherosclerosis in diabetic and non-diabetic patients with rheumatoid arthritis. Pak J Med Sci. 2015;31(5):1078-83doi: 10.12669/pjms.315.7620.
Kisiel, B., Kruszewski, R., Juszkiewicz, A., Kłos, K., Tłustochowicz, M., & Tłustochowicz, W. (2015). Prevalence of Atherosclerosis in diabetic and non-diabetic patients with rheumatoid arthritis. Pakistan journal of medical sciences, 31(5), 1078-83. https://doi.org/10.12669/pjms.315.7620
Kisiel, Bartłomiej, et al. "Prevalence of Atherosclerosis in diabetic and non-diabetic patients with rheumatoid arthritis." Pakistan journal of medical sciences vol. 31,5 (2015): 1078-83. doi: https://doi.org/10.12669/pjms.315.7620
Kisiel B, Kruszewski R, Juszkiewicz A, Kłos K, Tłustochowicz M, Tłustochowicz W. Prevalence of Atherosclerosis in diabetic and non-diabetic patients with rheumatoid arthritis. Pak J Med Sci. 2015 Sep-Oct;31(5):1078-83. doi: 10.12669/pjms.315.7620. PMID: 26648990; PMCID: PMC4641259.
Copy Download .nbib Format: NLM
Treat-to-target therapy does not prevent excessive progression of carotid intima media thickness during the first year of therapy in early rheumatoid arthritis.

Archives of medical sciences. Atherosclerotic diseases

Raczkiewicz A, Juszkiewicz A, Kisiel B, Bachta A, Kur-Zalewska J, Kłos K, Bujakowska O, Tłustochowicz M, Tłustochowicz W.
PMID: 28905017
Arch Med Sci Atheroscler Dis. 2016 May 30;1(1):e36-e43. doi: 10.5114/amsad.2016.60225. eCollection 2016.

INTRODUCTION: The aim of the study was to investigate the presence of subclinical atherosclerosis and predictors of change in carotid intima-media measures in early rheumatoid arthritis patients (eRA) as compared to chronic RA patients and patients without arthritis.MATERIAL AND...

Cite
Raczkiewicz A, Juszkiewicz A, Kisiel B, et al. Treat-to-target therapy does not prevent excessive progression of carotid intima media thickness during the first year of therapy in early rheumatoid arthritis. Arch Med Sci Atheroscler Dis. 2016;1(1):e36-e43doi: 10.5114/amsad.2016.60225.
Raczkiewicz, A., Juszkiewicz, A., Kisiel, B., Bachta, A., Kur-Zalewska, J., Kłos, K., Bujakowska, O., Tłustochowicz, M., & Tłustochowicz, W. (2016). Treat-to-target therapy does not prevent excessive progression of carotid intima media thickness during the first year of therapy in early rheumatoid arthritis. Archives of medical sciences. Atherosclerotic diseases, 1(1), e36-e43. https://doi.org/10.5114/amsad.2016.60225
Raczkiewicz, Anna, et al. "Treat-to-target therapy does not prevent excessive progression of carotid intima media thickness during the first year of therapy in early rheumatoid arthritis." Archives of medical sciences. Atherosclerotic diseases vol. 1,1 (2016): e36-e43. doi: https://doi.org/10.5114/amsad.2016.60225
Raczkiewicz A, Juszkiewicz A, Kisiel B, Bachta A, Kur-Zalewska J, Kłos K, Bujakowska O, Tłustochowicz M, Tłustochowicz W. Treat-to-target therapy does not prevent excessive progression of carotid intima media thickness during the first year of therapy in early rheumatoid arthritis. Arch Med Sci Atheroscler Dis. 2016 May 30;1(1):e36-e43. doi: 10.5114/amsad.2016.60225. eCollection 2016. PMID: 28905017; PMCID: PMC5421530.
Copy Download .nbib Format: NLM
Prevalence of psoriatic arthritis and costs generated by treatment of psoriatic arthritis patients in the public health system - the case of Poland.

Reumatologia

Raciborski F, Śliwczyński A, Kłak A, Kwiatkowska B, Brzozowska M, Tłustochowicz M.
PMID: 28115777
Reumatologia. 2016;54(6):278-284. doi: 10.5114/reum.2016.64902. Epub 2016 Dec 30.

OBJECTIVE: The objective of the study was to analyse the prevalence of psoriatic arthritis (PsA) in Poland and to assess the costs generated by treatment of PsA patients in the system of public healthcare.MATERIAL AND METHODS: The analysis was...

Cite
Raciborski F, Śliwczyński A, Kłak A, et al. Prevalence of psoriatic arthritis and costs generated by treatment of psoriatic arthritis patients in the public health system - the case of Poland. Reumatologia. 2016;54(6):278-284doi: 10.5114/reum.2016.64902.
Raciborski, F., Śliwczyński, A., Kłak, A., Kwiatkowska, B., Brzozowska, M., & Tłustochowicz, M. (2016). Prevalence of psoriatic arthritis and costs generated by treatment of psoriatic arthritis patients in the public health system - the case of Poland. Reumatologia, 54(6), 278-284. https://doi.org/10.5114/reum.2016.64902
Raciborski, Filip, et al. "Prevalence of psoriatic arthritis and costs generated by treatment of psoriatic arthritis patients in the public health system - the case of Poland." Reumatologia vol. 54,6 (2016): 278-284. doi: https://doi.org/10.5114/reum.2016.64902
Raciborski F, Śliwczyński A, Kłak A, Kwiatkowska B, Brzozowska M, Tłustochowicz M. Prevalence of psoriatic arthritis and costs generated by treatment of psoriatic arthritis patients in the public health system - the case of Poland. Reumatologia. 2016;54(6):278-284. doi: 10.5114/reum.2016.64902. Epub 2016 Dec 30. PMID: 28115777; PMCID: PMC5241363.
Copy Download .nbib Format: NLM
Sequentiality of treatment in the rheumatoid arthritis drug programme in the years 2009-2014.

Archives of medical science : AMS

Tłustochowicz M, Śliwczyński AM, Brzozowska M, Teter Z, Marczak M.
PMID: 29765444
Arch Med Sci. 2018 Apr;14(3):569-571. doi: 10.5114/aoms.2016.58924. Epub 2016 Mar 31.

Approximately 1% of the population suffers from rheumatoid arthritis (RA) worldwide (0.45% in Poland). The therapy consists of the use of disease-modifying antirheumatic drugs (DMARDs). Biologics are used in the form of the drug programme. Analysis of the NHF...

Cite
Tłustochowicz M, Śliwczyński AM, Brzozowska M, et al. Sequentiality of treatment in the rheumatoid arthritis drug programme in the years 2009-2014. Arch Med Sci. 2016;14(3):569-571doi: 10.5114/aoms.2016.58924.
Tłustochowicz, M., Śliwczyński, A. M., Brzozowska, M., Teter, Z., & Marczak, M. (2018). Sequentiality of treatment in the rheumatoid arthritis drug programme in the years 2009-2014. Archives of medical science : AMS, 14(3), 569-571. https://doi.org/10.5114/aoms.2016.58924
Tłustochowicz, Małgorzata, et al. "Sequentiality of treatment in the rheumatoid arthritis drug programme in the years 2009-2014." Archives of medical science : AMS vol. 14,3 (2018): 569-571. doi: https://doi.org/10.5114/aoms.2016.58924
Tłustochowicz M, Śliwczyński AM, Brzozowska M, Teter Z, Marczak M. Sequentiality of treatment in the rheumatoid arthritis drug programme in the years 2009-2014. Arch Med Sci. 2018 Apr;14(3):569-571. doi: 10.5114/aoms.2016.58924. Epub 2016 Mar 31. PMID: 29765444; PMCID: PMC5949902.
Copy Download .nbib Format: NLM
Early Myocardial Changes in Patients with Rheumatoid Arthritis without Known Cardiovascular Diseases-A Comprehensive Cardiac Magnetic Resonance Study.

Diagnostics (Basel, Switzerland)

Malczuk E, Tłustochowicz W, Kramarz E, Kisiel B, Marczak M, Tłustochowicz M, Małek ŁA.
PMID: 34943529
Diagnostics (Basel). 2021 Dec 07;11(12). doi: 10.3390/diagnostics11122290.

Clinically silent cardiac disease is frequently observed in rheumatoid arthritis (RA), and cardiovascular complications are the leading cause of mortality in RA. We sought to evaluate the myocardium of young RA patients without known cardiac disease using cardiac magnetic...

Cite
Malczuk E, Tłustochowicz W, Kramarz E, et al. Early Myocardial Changes in Patients with Rheumatoid Arthritis without Known Cardiovascular Diseases-A Comprehensive Cardiac Magnetic Resonance Study. Diagnostics (Basel). 2021;11(12)doi: 10.3390/diagnostics11122290.
Malczuk, E., Tłustochowicz, W., Kramarz, E., Kisiel, B., Marczak, M., Tłustochowicz, M., & Małek, �. �. A. (2021). Early Myocardial Changes in Patients with Rheumatoid Arthritis without Known Cardiovascular Diseases-A Comprehensive Cardiac Magnetic Resonance Study. Diagnostics (Basel, Switzerland), 11(12), . https://doi.org/10.3390/diagnostics11122290
Malczuk, Ewa, et al. "Early Myocardial Changes in Patients with Rheumatoid Arthritis without Known Cardiovascular Diseases-A Comprehensive Cardiac Magnetic Resonance Study." Diagnostics (Basel, Switzerland) vol. 11,12 (2021). doi: https://doi.org/10.3390/diagnostics11122290
Malczuk E, Tłustochowicz W, Kramarz E, Kisiel B, Marczak M, Tłustochowicz M, Małek ŁA. Early Myocardial Changes in Patients with Rheumatoid Arthritis without Known Cardiovascular Diseases-A Comprehensive Cardiac Magnetic Resonance Study. Diagnostics (Basel). 2021 Dec 07;11(12). doi: 10.3390/diagnostics11122290. PMID: 34943529.
Copy Download .nbib Format: NLM
Early Myocardial Changes in Patients with Rheumatoid Arthritis without Known Cardiovascular Diseases-A Comprehensive Cardiac Magnetic Resonance Study.

Diagnostics (Basel, Switzerland)

Malczuk E, Tłustochowicz W, Kramarz E, Kisiel B, Marczak M, Tłustochowicz M, Małek ŁA.
PMID: 34943529
Diagnostics (Basel). 2021 Dec 07;11(12). doi: 10.3390/diagnostics11122290.

Clinically silent cardiac disease is frequently observed in rheumatoid arthritis (RA), and cardiovascular complications are the leading cause of mortality in RA. We sought to evaluate the myocardium of young RA patients without known cardiac disease using cardiac magnetic...

Cite
Malczuk E, Tłustochowicz W, Kramarz E, et al. Early Myocardial Changes in Patients with Rheumatoid Arthritis without Known Cardiovascular Diseases-A Comprehensive Cardiac Magnetic Resonance Study. Diagnostics (Basel). 2021;11(12)doi: 10.3390/diagnostics11122290.
Malczuk, E., Tłustochowicz, W., Kramarz, E., Kisiel, B., Marczak, M., Tłustochowicz, M., & Małek, �. �. A. (2021). Early Myocardial Changes in Patients with Rheumatoid Arthritis without Known Cardiovascular Diseases-A Comprehensive Cardiac Magnetic Resonance Study. Diagnostics (Basel, Switzerland), 11(12), . https://doi.org/10.3390/diagnostics11122290
Malczuk, Ewa, et al. "Early Myocardial Changes in Patients with Rheumatoid Arthritis without Known Cardiovascular Diseases-A Comprehensive Cardiac Magnetic Resonance Study." Diagnostics (Basel, Switzerland) vol. 11,12 (2021). doi: https://doi.org/10.3390/diagnostics11122290
Malczuk E, Tłustochowicz W, Kramarz E, Kisiel B, Marczak M, Tłustochowicz M, Małek ŁA. Early Myocardial Changes in Patients with Rheumatoid Arthritis without Known Cardiovascular Diseases-A Comprehensive Cardiac Magnetic Resonance Study. Diagnostics (Basel). 2021 Dec 07;11(12). doi: 10.3390/diagnostics11122290. PMID: 34943529; PMCID: PMC8699890.
Copy Download .nbib Format: NLM
Changes in the morbidity and costs of systemic lupus erythematosus in Poland in the years 2008-2012.

Reumatologia

Śliwczyński A, Brzozowska M, Iltchev P, Czeleko T, Teter Z, Tłustochowicz W, Marczak M, Tłustochowicz M.
PMID: 27407232
Reumatologia. 2015;53(2):79-86. doi: 10.5114/reum.2015.51507. Epub 2015 May 18.

OBJECTIVES: The goal of the article is to present the changes in morbidity and costs of systemic lupus erythematosus (SLE) in Poland in the 2008-2012 period, depending on the province of residence of the patients based on data reported...

Cite
Śliwczyński A, Brzozowska M, Iltchev P, et al. Changes in the morbidity and costs of systemic lupus erythematosus in Poland in the years 2008-2012. Reumatologia. 2015;53(2):79-86doi: 10.5114/reum.2015.51507.
Śliwczyński, A., Brzozowska, M., Iltchev, P., Czeleko, T., Teter, Z., Tłustochowicz, W., Marczak, M., & Tłustochowicz, M. (2015). Changes in the morbidity and costs of systemic lupus erythematosus in Poland in the years 2008-2012. Reumatologia, 53(2), 79-86. https://doi.org/10.5114/reum.2015.51507
Śliwczyński, Andrzej, et al. "Changes in the morbidity and costs of systemic lupus erythematosus in Poland in the years 2008-2012." Reumatologia vol. 53,2 (2015): 79-86. doi: https://doi.org/10.5114/reum.2015.51507
Śliwczyński A, Brzozowska M, Iltchev P, Czeleko T, Teter Z, Tłustochowicz W, Marczak M, Tłustochowicz M. Changes in the morbidity and costs of systemic lupus erythematosus in Poland in the years 2008-2012. Reumatologia. 2015;53(2):79-86. doi: 10.5114/reum.2015.51507. Epub 2015 May 18. PMID: 27407232; PMCID: PMC4847273.
Copy Download .nbib Format: NLM
Satisfaction and discontent of Polish patients with biological therapy of rheumatic diseases: results of a multi-center questionnaire study.

Reumatologia

Kotulska A, Kucharz EJ, Wiland P, Olesińska M, Felis-Giemza A, Kopeć-Mędrek M, Zoń-Giebel A, Romanowski W, Szymczak-Bartz L, Tłustochowicz M, Lewandowicz J, Kowalska-Majka J, Bucka J, Majdan M, Kiełbik Z, Korkosz M, Bielińska A, Leszczyński P, Pawlak-Buś K, Puszczewicz MJ, Majewski D, Smolik K, Migas-Kukla T, Sochocka-Bykowska M, Szarecka M, Luberda B, Falenta-Hitnarowicz M, Świkszcz-Gniadek J, Lepiarz-Rusek W, Rozwadowski G, Chara B, Zajdel J, Zdrojewski Z, Maciejowska-Roge M, Rosmus-Kuczia I.
PMID: 30042601
Reumatologia. 2018;56(3):140-148. doi: 10.5114/reum.2018.76901. Epub 2018 Jun 30.

OBJECTIVES: Biologics are medications widely applied in the management of inflammatory rheumatic diseases. The drugs were found to be effective but their application is associated with some disadvantages. Medication with biologics is relatively expensive, and in Poland, it is...

Cite
Kotulska A, Kucharz EJ, Wiland P, et al. Satisfaction and discontent of Polish patients with biological therapy of rheumatic diseases: results of a multi-center questionnaire study. Reumatologia. 2018;56(3):140-148doi: 10.5114/reum.2018.76901.
Kotulska, A., Kucharz, E. J., Wiland, P., Olesińska, M., Felis-Giemza, A., Kopeć-Mędrek, M., Zoń-Giebel, A., Romanowski, W., Szymczak-Bartz, L., Tłustochowicz, M., Lewandowicz, J., Kowalska-Majka, J., Bucka, J., Majdan, M., Kiełbik, Z., Korkosz, M., Bielińska, A., Leszczyński, P., Pawlak-Buś, K., Puszczewicz, M. J., Majewski, D., Smolik, K., Migas-Kukla, T., Sochocka-Bykowska, M., Szarecka, M., Luberda, B., Falenta-Hitnarowicz, M., Świkszcz-Gniadek, J., Lepiarz-Rusek, W., Rozwadowski, G., Chara, B., Zajdel, J., Zdrojewski, Z., Maciejowska-Roge, M., & Rosmus-Kuczia, I. (2018). Satisfaction and discontent of Polish patients with biological therapy of rheumatic diseases: results of a multi-center questionnaire study. Reumatologia, 56(3), 140-148. https://doi.org/10.5114/reum.2018.76901
Kotulska, Anna, et al. "Satisfaction and discontent of Polish patients with biological therapy of rheumatic diseases: results of a multi-center questionnaire study." Reumatologia vol. 56,3 (2018): 140-148. doi: https://doi.org/10.5114/reum.2018.76901
Kotulska A, Kucharz EJ, Wiland P, Olesińska M, Felis-Giemza A, Kopeć-Mędrek M, Zoń-Giebel A, Romanowski W, Szymczak-Bartz L, Tłustochowicz M, Lewandowicz J, Kowalska-Majka J, Bucka J, Majdan M, Kiełbik Z, Korkosz M, Bielińska A, Leszczyński P, Pawlak-Buś K, Puszczewicz MJ, Majewski D, Smolik K, Migas-Kukla T, Sochocka-Bykowska M, Szarecka M, Luberda B, Falenta-Hitnarowicz M, Świkszcz-Gniadek J, Lepiarz-Rusek W, Rozwadowski G, Chara B, Zajdel J, Zdrojewski Z, Maciejowska-Roge M, Rosmus-Kuczia I. Satisfaction and discontent of Polish patients with biological therapy of rheumatic diseases: results of a multi-center questionnaire study. Reumatologia. 2018;56(3):140-148. doi: 10.5114/reum.2018.76901. Epub 2018 Jun 30. PMID: 30042601; PMCID: PMC6052366.
Copy Download .nbib Format: NLM
Rheumatoid arthritis treatment with TNF inhibitors and alternative procedures in case of its failure - results of the Polish survey in the context of EULAR recommendations.

Reumatologia

Tłustochowicz M, Dębowska G, Spytek J, Tłustochowicz W.
PMID: 27407248
Reumatologia. 2015;53(4):200-6. doi: 10.5114/reum.2015.53997. Epub 2015 Sep 22.

INTRODUCTION: According to the European League Against Rheumatism (EULAR), rheumatoid arthritis (RA) treatment aims to achieve remission or low disease activity (LDA) within 6 months. In Poland, despite the existence of the National Health Fund Drug Program (NHF-DP), data...

Cite
Tłustochowicz M, Dębowska G, Spytek J, et al. Rheumatoid arthritis treatment with TNF inhibitors and alternative procedures in case of its failure - results of the Polish survey in the context of EULAR recommendations. Reumatologia. 2015;53(4):200-6doi: 10.5114/reum.2015.53997.
Tłustochowicz, M., Dębowska, G., Spytek, J., & Tłustochowicz, W. (2015). Rheumatoid arthritis treatment with TNF inhibitors and alternative procedures in case of its failure - results of the Polish survey in the context of EULAR recommendations. Reumatologia, 53(4), 200-6. https://doi.org/10.5114/reum.2015.53997
Tłustochowicz, Małgorzata, et al. "Rheumatoid arthritis treatment with TNF inhibitors and alternative procedures in case of its failure - results of the Polish survey in the context of EULAR recommendations." Reumatologia vol. 53,4 (2015): 200-6. doi: https://doi.org/10.5114/reum.2015.53997
Tłustochowicz M, Dębowska G, Spytek J, Tłustochowicz W. Rheumatoid arthritis treatment with TNF inhibitors and alternative procedures in case of its failure - results of the Polish survey in the context of EULAR recommendations. Reumatologia. 2015;53(4):200-6. doi: 10.5114/reum.2015.53997. Epub 2015 Sep 22. PMID: 27407248; PMCID: PMC4847287.
Copy Download .nbib Format: NLM
MRI evaluation of pathological changes taking place in the hand in patients with rheumatoid arthritis.

Ortopedia, traumatologia, rehabilitacja

Andrysiak R, Ciechomska A, Królicki A, Mianowicz J, Tłustochowicz W.
PMID: 17984888
Ortop Traumatol Rehabil. 2000 Dec 30;2(4):78-82.

The aim of this study was to use magnetic resonance imaging (MRI) to evaluate the pathological changes taking place in the hands of patients with rheumatoid arthritis (RA), and to attempt to characterize early and persistent changes. 42 patients...

Cite
Andrysiak R, Ciechomska A, Królicki A, et al. MRI evaluation of pathological changes taking place in the hand in patients with rheumatoid arthritis. Ortop Traumatol Rehabil. 2000;2(4):78-82
Andrysiak, R., Ciechomska, A., Królicki, A., Mianowicz, J., & Tłustochowicz, W. (2000). MRI evaluation of pathological changes taking place in the hand in patients with rheumatoid arthritis. Ortopedia, traumatologia, rehabilitacja, 2(4), 78-82.
Andrysiak, R, et al. "MRI evaluation of pathological changes taking place in the hand in patients with rheumatoid arthritis." Ortopedia, traumatologia, rehabilitacja vol. 2,4 (2000): 78-82.
Andrysiak R, Ciechomska A, Królicki A, Mianowicz J, Tłustochowicz W. MRI evaluation of pathological changes taking place in the hand in patients with rheumatoid arthritis. Ortop Traumatol Rehabil. 2000 Dec 30;2(4):78-82. PMID: 17984888.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries